Insider · CIK 0001892413
Emil Kuriakose
officer
Files at TERN (Terns Pharmaceuticals, Inc.). First filing Jan 6, 2025, latest Jul 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $32k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | TERNsell Terns Pharmaceuticals, Inc. | $3,640 853 shares | -2% | - | |
| 15Weak | TERNsell Terns Pharmaceuticals, Inc. | $2,366 952 shares | -2% | - | |
| 20Weak | TERNsell Terns Pharmaceuticals, Inc. | $26k 4,481 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | TERN Terns Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -853 | $4.27 | $3,640 | 52,464 | Jul 3, 2025 |
| Apr 1, 2025 | TERN Terns Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -952 | $2.49 | $2,366 | 53,317 | Apr 2, 2025 |
| Jan 30, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +485,000 | $0.00 | $0 | 485,000 | Feb 3, 2025 |
| Jan 2, 2025 | TERN Terns Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,481 | $5.71 | $26k | 54,269 | Jan 6, 2025 |
| Dec 12, 2024 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.